SANGAMO THERAPEUTICS INC (SGMO) Stock Balance Sheet
NASDAQ:SGMO - Nasdaq - US8006771062 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 25.18M | 41.92M | 45.20M | 100.40M | 178.90M | |||
| Marketable Securities | N/A | 0.00 | 35.80M | 177.20M | 197.70M | |||
| Receivables | 4.61M | 4.60M | 1.33M | 4.50M | 6.40M | |||
| Other Current Assets | 7.81M | 5.17M | 12.00M | 18.20M | 15.90M | |||
| Total Current Assets | 37.60M | 51.69M | 94.33M | 300.30M | 398.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 32.84M | 34.76M | 52.87M | 125.50M | 124.70M | |||
| Investments And Advances | N/A | N/A | 0.00 | 29.80M | 88.20M | |||
| Goodwill | N/A | 0.00 | 0.00 | 37.60M | 39.70M | |||
| Intangibles | N/A | 0.00 | 0.00 | 50.70M | 53.80M | |||
| Other Non-Current Assets | 2.38M | 2.38M | 18.13M | 18.50M | 16.80M | |||
| Total Non-Current Assets | 48.57M | 49.94M | 70.99M | 262.20M | 323.10M | |||
| TOTAL ASSETS | 86.17M | 101.64M | 165.32M | 562.50M | 721.90M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 23.80M | 20.46M | 20.74M | 34.40M | 30.60M | |||
| Accounts Payable | 18.20M | 15.48M | 15.26M | 22.40M | 9.80M | |||
| Other Current Liabilities | 7.56M | 9.86M | 11.73M | 54.80M | 87.50M | |||
| Total Current Liabilities | 49.56M | 45.80M | 47.73M | 111.70M | 127.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | 15.00K | N/A | 0.00 | 6.30M | 6.60M | |||
| Other Non-Current Liabilities | 31.68M | 33.06M | 34.70M | 149.60M | 212.00M | |||
| Total Non-Current Liabilities | 31.70M | 33.06M | 34.70M | 155.90M | 218.70M | |||
| TOTAL LIABILITIES | 81.26M | 78.86M | 82.43M | 267.60M | 346.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.53B | -1.50B | -1.41B | -1.15B | -956.30M | |||
| Additional Paid In Capital | 1.54B | 1.53B | 1.49B | 1.45B | 1.33B | |||
| Minority Interest | N/A | N/A | N/A | N/A | 0.00 | |||
| Common Shares | 2.25M | 2.13M | 1.78M | 1.70M | 1.50M | |||
| Other Shareholders' Equity | -5.53M | -7.53M | -4.59M | -8.40M | -4.00M | |||
| Shares Outstanding | 225.36M | 212.84M | 178.13M | 166.80M | 145.90M | |||
| Tangible Book Value per Share | 0.02 | 0.11 | 0.47 | 1.24 | 1.93 | |||
| Total Shareholders' Equity | 4.91M | 22.77M | 82.89M | 295.00M | 375.30M | |||
| TOTAL LIABILITIES AND EQUITY | 86.17M | 101.64M | 165.32M | 562.50M | 721.90M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 0.76 | 1.13 | 1.98 | 2.69 | 3.12 | |||
| Return On Assets (ROA) | -149.17% | -96.37% | -155.96% | -34.19% | -24.70% | |||
| Return On Equity (ROE) | -2620.02% | -430.13% | -311.06% | -65.19% | -47.51% | |||
All data in USD , ROIC based on taxRate of 0.21